Skip to content
New: Explore the psychedelic pipeline via our Q3'25 🎯 Bullseye Charts.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

  • Post published:October 12, 2022
  • Post category:Press Release
Read more about the article Reunion Neuroscience Inc. Announces Executive Changes

Reunion Neuroscience Inc. Announces Executive Changes

  • Post published:October 7, 2022
  • Post category:Press Release
Read more about the article Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference

Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference

  • Post published:October 4, 2022
  • Post category:Press Release
Read more about the article Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting

Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting

  • Post published:September 30, 2022
  • Post category:Press Release
Read more about the article Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer

Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer

  • Post published:September 28, 2022
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More